Clinical Trials Directory

Trials / Unknown

UnknownNCT04238611

Minimally-Invasive Realtime Assessment of Continuous Lactate in Exercise

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
15 (estimated)
Sponsor
Imperial College London · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Lactate is a compound produced as a by-product of glycolysis. The increase in lactate concentration can result from a variety of causes, such as during anaerobic metabolism in exercise or haemodynamic shock in conditions such as sepsis. The study will aim to validate a novel microneedle-based minimally invasive device for the continuous measurement of lactate during exercise.

Detailed description

Lactate is a compound produced as a by-product of glycolysis. The increase in lactate concentration can result from a variety of causes, such as during anaerobic metabolism in exercise. The measurement of blood lactate during exercise has been routinely used to determine individual anaerobic thresholds, and optimise training in athletes. The measurement of the lactate trend requires multiple blood tests, and this can be uncomfortable. The need for repeated procedures may therefore restrict the full utility of the biomarker. Although point-of-care lactate measurements are possible, the barriers to initiating testing may also limit its role in clinical decision-making. The aim of the study is the validation of the microneedle-based lactate biosensor for real-time continuous lactate measurement in healthy volunteers during exercise as proof-of-concept.

Conditions

Interventions

TypeNameDescription
DEVICEMicroneedleLactate microneedle applied on the skin of participant
DIAGNOSTIC_TESTBlood lactate measurementSerum lactate testing through conventional laboratory methods
OTHERExercise regimenStandardised aerobic exercise regimen

Timeline

Start date
2021-03-01
Primary completion
2021-09-01
Completion
2022-03-01
First posted
2020-01-23
Last updated
2021-08-26

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT04238611. Inclusion in this directory is not an endorsement.